New asthma drug shows promise in real-world greek study
NCT ID NCT05440656
First seen Apr 29, 2026 · Last updated May 12, 2026 · Updated 3 times
Summary
This study followed 152 adults in Greece with severe eosinophilic asthma who were starting benralizumab, a medication that helps control the condition. Over 48 weeks, researchers measured not only standard asthma control but also quality of life, sleep, mood, and physical activity using wearable trackers. The goal was to see how the drug works in routine care and how it affects patients' daily well-being.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE EOSINOPHILIC ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Alexandroupoli, 68100, Greece
-
Research Site
Athens, 11521, Greece
-
Research Site
Athens, 11527, Greece
-
Research Site
Athens, 12462, Greece
-
Research Site
Athens, 15125, Greece
-
Research Site
Athens, 17562, Greece
-
Research Site
Corfu, 49100, Greece
-
Research Site
Heraklion, 71500, Greece
-
Research Site
Ioannina, 45500, Greece
-
Research Site
Rio, 26504, Greece
-
Research Site
Thessaloniki, 55535, Greece
-
Research Site
Thessaloniki, 56429, Greece
-
Research Site
Thessaloniki, 57010, Greece
Conditions
Explore the condition pages connected to this study.